Skip to main content
. 2021 Jul 2;74(6):973–982. doi: 10.1093/cid/ciab598

Table 5.

Added Value of Human Immunodeficiency Virus–Related Disease Severity and NAT2 Acetylator Status

Metric Antiretroviral Therapy Experienced CD4 <200 Viral Load ≥200 NAT2
LR test P value .03 .81 .47 .88
Net reclassification index 0.24 <0.01 0.16 0.13
Integrated discrimination improvement 0.01 <0.01 <0.01 <0.01
Fraction of new information based on comparison of model LRs 0.03 <0.01 <0.01 <0.01
Fraction of new information based on ratio of the variances explained by the models 0.03 <0.01 <0.01 <0.01
Fraction of new information based on variance of predicted risk to the sum of the variance of predicted risk and the average risk 0.03 <0.01 <0.01 <0.01

Abbreviation: LR, likelihood ratio.